DrugPatentWatch Database Preview
Ibritumomab tiuxetan - Biologic Drug Details
Try a free trial
See Plans and Pricing
Summary for ibritumomab tiuxetan
| Tradenames: | 1 |
| Patents: | 136 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ibritumomab tiuxetan |
US Patents for ibritumomab tiuxetan
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spectrum Pharms | ZEVALIN | ibritumomab tiuxetan | INJECTABLE; INJECTION | 125019 | 001 | 2002-02-19 | Try a Free Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | Orphan | search |
| Spectrum Pharms | ZEVALIN | ibritumomab tiuxetan | INJECTABLE; INJECTION | 125019 | 001 | 2002-02-19 | Try a Free Trial | YALE UNIVERSITY (New Haven, CT) | 2032-05-02 | RX | Orphan | search |
| Spectrum Pharms | ZEVALIN | ibritumomab tiuxetan | INJECTABLE; INJECTION | 125019 | 001 | 2002-02-19 | Try a Free Trial | NOXXON Pharma AG (Berlin, DE) | 2030-09-09 | RX | Orphan | search |
| Spectrum Pharms | ZEVALIN | ibritumomab tiuxetan | INJECTABLE; INJECTION | 125019 | 001 | 2002-02-19 | Try a Free Trial | YALE UNIVERSITY (New Haven, CT) | 2038-11-11 | RX | Orphan | search |
| Spectrum Pharms | ZEVALIN | ibritumomab tiuxetan | INJECTABLE; INJECTION | 125019 | 001 | 2002-02-19 | Try a Free Trial | Plexxikon Inc. (Berkeley, CA) | 2036-03-16 | RX | Orphan | search |
| Spectrum Pharms | ZEVALIN | ibritumomab tiuxetan | INJECTABLE; INJECTION | 125019 | 001 | 2002-02-19 | Try a Free Trial | GENOSCIENCE PHARMA (Marseilles, FR) | 2039-01-16 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for ibritumomab tiuxetan
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2006262907 | Try a Free Trial |
| Australia | 2007230822 | Try a Free Trial |
| European Patent Office | 2917195 | Try a Free Trial |
| Japan | 2014514345 | Try a Free Trial |
| Japan | 2016509583 | Try a Free Trial |
| European Patent Office | 2791164 | Try a Free Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ibritumomab tiuxetan
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2004000036 | Germany | Try a Free Trial | FORMER OWNER: BIOGEN IDEC INC.(N.D.GES.D.STAATES DELAWARE), SAN DIEGO, CALIF., US |
| 780 | Luxembourg | Try a Free Trial | PRODUCT NAME: TRASTUZUMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20130826 |
| C0018 | France | Try a Free Trial | PRODUCT NAME: IBRITUMOMAB TIUXETAN; REGISTRATION NO/DATE: EU/1/03/264/001 20040116 |
| 089 | Luxembourg | Try a Free Trial | 91089, EXPIRES: 20181112 |
| 620 | Luxembourg | Try a Free Trial | 91620, EXPIRES: 20181112 |
| 0822 | Netherlands | Try a Free Trial | PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
